Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

A Phase 1/2 Study of BA3071 in Patients With Solid Tumors

NCT05180799

Conditions
Melanoma, NSCLC, Neoplasm Metastasis, +14 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Piedmont West Atlanta, Georgia, United States
  • Northwest Cancer Centers Dyer, Indiana, United States
View Trial Details
Active, Not Recruiting

Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma

NCT02743819

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Mount Sinai Medical Center of Florida Miami Beach, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients

NCT04385732

Conditions
Anxiety Disorders, Anxiety and Fear, Melanoma, +13 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Newcastle Skin Check Newcastle, New South Wales, Australia
  • Dermatology Clinical Trials Unit, Westmead Hospital Sydney, New South Wales, Australia
  • Melanoma Institute Australia Wollstonecraft, New South Wales, Australia
View Trial Details
Active, Not Recruiting

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

NCT05664243

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Louisville Hospital/James Graham Brown Cancer Center Louisville, Kentucky, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details

Related conditions